Related Experiment Videos
Surgery for hyperthyroidism: indications, pretreatment, operative strategy and results
Annales Chirurgiae Et Gynaecologiae
|January 1, 1983
Summary
Surgery is recommended for nodular toxic goiter due to high recurrence rates with other treatments. For Graves' disease, surgery is an option for severe cases or younger patients, with low operative risk.
Area of Science:
- Endocrinology
- Thyroidology
- Surgical Oncology
Background:
- Nodular toxic goiter dominates hyperthyroidism in endemic areas, unlike Graves' disease (25-30%).
- Antithyroid drugs have poor long-term efficacy (50-60% recurrence), and radioiodine often requires higher doses or repeat treatments.
Purpose of the Study:
- To evaluate the primary treatment of choice for nodular toxic goiter and Graves' disease.
- To assess the role and safety of surgery in hyperthyroid management.
- To analyze surgical outcomes in a large patient cohort.
Main Methods:
- Retrospective analysis of 702 patients from three hospitals.
- Comparison of treatment outcomes for nodular toxic goiter and Graves' disease.
- Evaluation of preoperative treatment strategies and surgical risks.
Main Results:
- Surgery is recommended as the primary treatment for nodular hyperthyroid goiter.
- Surgery is indicated for severe Graves' disease, larger goiters, or patients under 40.
- Antithyroid drugs are preferred for preoperative treatment; iodine and beta-blockers are alternatives for moderate cases.
- Acceptable surgical risk: 0.5-1.5% with minimal mortality.
Conclusions:
- Surgery is the preferred primary treatment for nodular toxic goiter.
- Surgical intervention is a viable and safe option for specific patient groups with Graves' disease.
- Careful patient selection and preoperative management optimize surgical outcomes for hyperthyroidism.